Brind.

Bio-Rad Laboratories acquired Stilla Technologies and received $250 million from Sartorius AG shares.

1 report, 1 independent Updated Aug 1
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Bio-Rad Laboratories acquired Stilla Technologies and received $250 million from Sartorius AG shares.

Who's involved

What this event is mainly about
Sartorius AGBio-Rad Laboratories

Keep exploring

The entities involved

  • Sartorius AG

    German technology company specializing in equipment and services for the biopharmaceutical industry

    Nothing else this week.

  • Bio-Rad Laboratories

    American life science research firm

    Nothing else this week.

Coverage

Newest first; wire copies grouped
  • GuruFocus.comBio-Rad Laboratories Inc (BIO) Q2 2025 Earnings Call Highlights: Navigating Growth Amidst Challenges Net Sales: $652 million, a 2.1% increase from $638 million in Q2 2024. Life Science Group Sales: $